Vitamin Blue Statistics
Vitamin Blue (VTMB) Stock Statistics & Valuation Metrics
Total Valuation
Vitamin Blue has a market cap or net worth of $783.00. The enterprise value is $406.28B.
- Market Cap
- $783.00
- Enterprise Value
- $406.28B
Share Statistics
Vitamin Blue has 783,405,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 783,405,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Vitamin Blue’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 8.05%.
- Return on Equity (ROE)
- 0.03
- Return on Assets (ROA)
- -0.66
- Return on Invested Capital (ROIC)
- 8.05%
- Return on Capital Employed (ROCE)
- 0.05
- Revenue Per Employee
- 250.03K
- Profits Per Employee
- -21.08K
- Employee Count
- 1
- Asset Turnover
- 7.88
- Inventory Turnover
- 16.23
Valuation Ratios
The current PE Ratio of Vitamin Blue is -7.84. Vitamin Blue’s PEG ratio is -0.08.
- PE Ratio
- -7.84
- PS Ratio
- 0.31
- PB Ratio
- -0.22
- Price to FCF
- 116.58
- Price to Operating Cash Flow
- 21.50
- PEG Ratio
- -0.08
Income Statement
In the last 12 months, Vitamin Blue had revenue of 250.03K and earned -21.08K in profits. Earnings per share was 0.00.
- Revenue
- 250.03K
- Gross Profit
- 96.51K
- Operating Income
- -34.32K
- Pretax Income
- -21.08K
- Net Income
- -21.08K
- EBITDA
- -2,852
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was 7,353 and capital expenditures -1,733, giving a free cash flow of 5,620 billion.
- Operating Cash Flow
- 7,353
- Free Cash Flow
- 5,620
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Vitamin Blue pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.86%
- Earnings Yield
- -12.75%
Stock Price Statistics
- Beta
- 0.00
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Vitamin Blue as a current ratio of 0.03, with Debt / Equity ratio of -43.64%
- Current Ratio
- 0.03
- Quick Ratio
- 0.02
- Debt to Market Cap
- 0.29
- Net Debt to EBITDA
- -114.99
- Interest Coverage Ratio
- -2.05
Taxes
In the past 12 months, Vitamin Blue has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Vitamin Blue EV to EBITDA ratio is -142.46, with an EV/FCF ratio of 604.59.
- EV to Sales
- 1.62
- EV to EBITDA
- -142.46
- EV to Free Cash Flow
- 604.59
- EV to Operating Cash Flow
- 52.84
Balance Sheet
Vitamin Blue has $5,449.00 in cash and marketable securities with $328.25K in debt, giving a net cash position of -$322.81K billion.
- Cash & Marketable Securities
- $5,449.00
- Total Debt
- $328.25K
- Net Cash
- -$322.81K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- ―
Margins
Gross margin is 38.60%, with operating margin of -13.73%, and net profit margin of -8.43%.
- Gross Margin
- 38.60%
- Operating Margin
- -13.73%
- Pretax Margin
- -8.43%
- Net Profit Margin
- -8.43%
- EBITDA Margin
- -1.14%
- EBIT Margin
- -1.73%
Analyst Forecast
The average price target for Vitamin Blue is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
